Sign in

    VALVOLINE (VVV)

    Q2 2025 Earnings Summary

    Reported on Jan 1, 1970 (Before Market Open)
    Pre-Earnings Price$34.57Last close (May 7, 2025)
    Post-Earnings Price$32.79Open (May 8, 2025)
    Price Change
    $-1.78(-5.15%)
    MetricYoY ChangeReason

    Net Revenues

    +3.8% (from $388.7M in Q2 2024 to $403.2M in Q2 2025)

    Despite modest revenue growth, the increase suggests steady topline demand. However, the limited growth compared to previous periods implies that expansion efforts or price adjustments did not translate into robust revenue increases, indicating potential market saturation or competitive pressure.

    Operating Income

    -12.4% (from $76.4M in Q2 2024 to $66.9M in Q2 2025)

    The decline in operating income, despite higher net revenues, indicates deteriorating operational efficiency or rising costs. This drop directly contrasts the modest revenue gain and suggests that cost pressures or margin compression – potentially from increased operating expenses – impacted profitability, reflecting a less favorable cost structure than in the previous period.

    Net Income

    -8.7% (from $41.4M in Q2 2024 to $37.6M in Q2 2025)

    The reduced net income mirrors the operating income weakness, implying that non-operating factors did little to offset the cost uptick seen on an operating basis. The smaller decline in net income relative to operating income may indicate partial mitigation from lower non-operating expenses or tax benefits compared to Q2 2024.

    Basic EPS

    Approximately -12% (from $0.33 in Q2 2024 to $0.29 in Q2 2025)

    Basic EPS fell in line with both operating and net income declines, reflecting lower earnings distributed over a similar share base. The drop suggests that the earnings dilution was not overcome by any gains in share count reductions, worsening the shareholder return contrast with the prior period.

    Total Assets

    -11.3% (from $2,763.0M in Q2 2024 to $2,452.6M in Q2 2025)

    The decline in total assets may indicate asset divestitures or write-downs. This contraction suggests that the company reduced its asset base, possibly as part of a strategic reallocation or to improve capital efficiency, contrasting with prior periods where a higher asset base supported revenue generation.

    Stockholders’ Equity

    Increased from $60.1M to $248.7M (Dramatic surge)

    The dramatic surge in equity is largely attributable to a reduction in common stock repurchases and strong net income performance relative to the previous period. The impact of lower repurchase activity (with repurchases drastically reduced compared to Q2 2024) helped preserve cash and enhance retained earnings, even as other comprehensive items fluctuated, signaling a rebalancing of the company’s capital structure.

    Total Current Assets

    Fell significantly (from $701.4M in Q2 2024 to $230.0M in Q2 2025)

    The substantial drop in current assets suggests a major shift in the company’s liquidity profile. This could be due to reclassification of assets, aggressive working capital management, or significant collection of receivables that reduced current balances compared to the prior period, imposing potential liquidity concerns or signaling strategic asset reallocation.

    Research analysts covering VALVOLINE.